Lenskart eyes on expansion in Indian retail market secures $100 million from ChrysCapital firm

▴ LENSKART FUNDING
With this investment, ChrysCapital aims to support Lenskart's innovative approach, customer-centric focus, and strategic partnerships to make a significant impact on the eyewear industry and address the pressing challenges of myopia worldwide

Indian eyewear startup Lenskart has secured $100 million in funding from private equity firm ChrysCapital, bringing its total capital raised in the past year to $850 million as it expands its offerings and reaches the Indian retail market. The investment was made through a combination of primary and secondary share purchases, bringing Lenskart's overall capital infusion to $850 million within the past year. The funding will be used to expand Lenskart's offerings and reach in India and internationally across Asia and the Middle East.

Who is ChrysCapital
ChrysCapital is a leading India-based investment advisory firm that was established in 1999. The firm has raised $5+ billion across eight funds, and its investors include institutions with a long-term horizon such as sovereign wealth funds, endowments, pension funds, and fund of funds. ChrysCapital has a successful track record of investing in information technology and business services, and it seeks to invest in companies operating in the business services, consumer goods and services, financial services, and healthcare sectors based in India.


Origin of lenskart
Lenskart was founded in 2010 by Peyush Bansal, Amit Chaudhary, and Sumeet Kapahi. Peyush Bansal, a former Microsoft employee, started the company with the goal of providing affordable and accessible eyewear to customers in India company began as an online platform but has since expanded to over 700 brick-and-mortar stores across more than 175 cities in India. In 2011, IDG Ventures India invested $4 million in the company, which helped Lenskart expand its offerings to include wristwatches, bags, and jewellery. Today, Lenskart is the largest eyewear platform in India, offering a range of products including eyeglasses, contact lenses, and sunglasses both online and offline.


• Peyush Bansal, CEO and founder of Lenskart stated that the funding will be used to expand the company's presence in India and to develop its technology

Current position
• As of 2021, the company had over 700 stores across more than 175 cities in India and had served over 10 million customers
• Headquartered in Gurgaon, Lenskart serves 20 million customers through its omni-channel approach and is expanding its presence beyond India to cover the Middle East and parts of Asia.
• This is an 80% expansion in value for the company, which was last valued at $ 2.5 billion following the close of a $315 million round in July 2021.

Future outlooks
• Lenskart has several future expansion plans, including going public within the next three years.
• The company also plans to open more than 500 stores across India in FY 2023 with a focus on strengthening its presence in tier two and three cities.
•The company is also focused on system scalability to handle the load of its 10X scalability expansion plans.

Tags : #lenskart #ChrysCapital #peyushbansal #funding #fundingalert #investment #eyecare #eyewear #middleeast #medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026